Reuters logo
BRIEF-Glenmark Pharma gets MHRA approval for anti-malarial medication as pharmacy license in UK
July 4, 2017 / 3:23 AM / 3 months ago

BRIEF-Glenmark Pharma gets MHRA approval for anti-malarial medication as pharmacy license in UK

July 4 (Reuters) - Glenmark Pharmaceuticals Ltd

* Says receives MHRA, UK approval for Maloff protect, anti-malarial medication as a pharmacy license in UK Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below